Lipid‐Lowering Drugs and Pulmonary Vascular Disease: A Mendelian Randomization Study
ABSTRACT The therapeutic value of lipid‐lowering drugs in pulmonary vascular disease remains uncertain due to insufficient studies and evidence. This study aims to investigate the causal effects of lipid‐lowering drugs (specifically, inhibitors of APOB, CETP, HMGCR, NPC1L1, and PCSK9) on pulmonary v...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Pulmonary Circulation |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/pul2.70043 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|